Unilever Balance Sheet Health
Financial Health criteria checks 3/6
Unilever has a total shareholder equity of €23.0B and total debt of €30.3B, which brings its debt-to-equity ratio to 131.6%. Its total assets and total liabilities are €79.8B and €56.8B respectively. Unilever's EBIT is €10.9B making its interest coverage ratio 15.2. It has cash and short-term investments of €6.4B.
Key information
131.6%
Debt to equity ratio
€30.30b
Debt
Interest coverage ratio | 15.2x |
Cash | €6.41b |
Equity | €23.02b |
Total liabilities | €56.81b |
Total assets | €79.83b |
Recent financial health updates
No updates
Recent updates
Unilever: Quality And Improving Growth Are Largely In The Price
Dec 13Unilever: A Path To Dividend Growth And Solid Returns Lies Ahead
Nov 13Unilever: This Giant Continues To Grow Step By Step
Oct 25Unilever Progressing On P&G Transformation Playbook
Sep 26Unilever: Nearing The Tipping Point
Aug 27Unilever: New CEO Making Impact
Aug 12Unilever: Unjustified Discount Despite Upping Its Performance
Jul 10Unilever: Recent Performance Has Removed The Margin Of Safety
Jun 06Unilever: The Company Is Moving In The Right Direction
Mar 24Unilever: Don't Expect Market Beating Returns
Feb 13Unilever: From Quantity Of Brands To Quality Of Brands
Jan 10Unilever Hasn't Been This Cheap Since More Than A Decade
Dec 20Unilever: New CEO Making Changes
Dec 04Unilever: Higher Quality Growth Needed
Nov 01Financial Position Analysis
Short Term Liabilities: UL's short term assets (€20.2B) do not cover its short term liabilities (€26.1B).
Long Term Liabilities: UL's short term assets (€20.2B) do not cover its long term liabilities (€30.7B).
Debt to Equity History and Analysis
Debt Level: UL's net debt to equity ratio (103.7%) is considered high.
Reducing Debt: UL's debt to equity ratio has reduced from 201.7% to 131.6% over the past 5 years.
Debt Coverage: UL's debt is well covered by operating cash flow (31.1%).
Interest Coverage: UL's interest payments on its debt are well covered by EBIT (15.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 01:36 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Unilever PLC is covered by 75 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Jan Vos | ABN AMRO Bank N.V. |
Pierre-Yves Gauthier | AlphaValue |
null null | Argus Research Company |